CBI, a division of UBM Life Sciences, is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic ...

In a clinical trial, the current status for participants, indicating at what stage the trial is. Before a trial begins, participants will be being recruited, and during a trial, participants will be ...

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market. Large CROs prioritise studies from the big pharma companies, for ...

THE THINGS THAT MAKE US TICKBeing the largest unified global healthcare networkBeing united under a single financial reporting structure: one agency with one P& LUsing a unique agency-of-the-future ...

Empowering Strategic Performance Ltd OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic Performance (ESP) in ...

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you ...

ScyTek Laboratories, Inc. a Utah, USA corporation involved in the manufacture of diagnostic reagents Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn ...

A healthcare related programme to monitor, maintain and improve medical practices and administration.

The largest professional body for public relations in the UK and Europe, with over 9,500 members accountable though a code of conduct, developing policies, representing fellow members, and raising ...

Creative Enzymes uses its expertise in enzyme manufacturing to supply customers enzymes using for life science research and production of medicines, food, alcohol, beer, fruit juice, fabric, paper, ...

Since 1994 Central Homecare has been building an enviable reputation as a high quality provider of high-tech’ home care in the UK.

A pricing strategy involving setting a relatively low price for a product during the introductory stage of its life-cycle to gain a share of the market which can be built upon.This strategy is ...